Skip to main content
. 2021 Aug 16;10(8):990. doi: 10.3390/antibiotics10080990

Figure 5.

Figure 5

(A) Schematic model of polymeric nanoparticles adapted from [115]. (B) PLGA nanoparticles with peptides as liver-target drug delivery system adapted from [43]. (C) Antibacterial process of polymeric nanoparticles [119].